PortalPublikationenPrevalence, predictors, and consequences of long-term refusa...

Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis.

Standard

Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis. / Lambert, Martin; Conus, Philippe; Cotton, Sue; Robinson, Jo; McGorry, Patrick D; Schimmelmann, Benno G.

in: J CLIN PSYCHOPHARM, Jahrgang 30, Nr. 5, 5, 2010, S. 565-572.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Lambert, M, Conus, P, Cotton, S, Robinson, J, McGorry, PD & Schimmelmann, BG 2010, 'Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis.', J CLIN PSYCHOPHARM, Jg. 30, Nr. 5, 5, S. 565-572. <http://www.ncbi.nlm.nih.gov/pubmed/20814327?dopt=Citation>

APA

Lambert, M., Conus, P., Cotton, S., Robinson, J., McGorry, P. D., & Schimmelmann, B. G. (2010). Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis. J CLIN PSYCHOPHARM, 30(5), 565-572. [5]. http://www.ncbi.nlm.nih.gov/pubmed/20814327?dopt=Citation

Vancouver

Lambert M, Conus P, Cotton S, Robinson J, McGorry PD, Schimmelmann BG. Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis. J CLIN PSYCHOPHARM. 2010;30(5):565-572. 5.

Bibtex

@article{e3edc11fec55438097bb247c9c22e893,
title = "Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis.",
abstract = "Studies investigating medication adherence in psychosis are limited by the need of a certain degree of medication adherence and the inclusion of mostly multiple-episode patients. By contrast, noninformed consent, epidemiological studies in first-episode psychosis (FEP) allow the assessment of an important subgroup of patients who persistently refuse antipsychotic medication and thereby never receive an adequate antipsychotic trial. The present study aims to assess the prevalence and predictors of such a {"}medication refusal{"} subgroup and its association with illness outcome.",
author = "Martin Lambert and Philippe Conus and Sue Cotton and Jo Robinson and McGorry, {Patrick D} and Schimmelmann, {Benno G}",
year = "2010",
language = "Deutsch",
volume = "30",
pages = "565--572",
journal = "J CLIN PSYCHOPHARM",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

RIS

TY - JOUR

T1 - Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis.

AU - Lambert, Martin

AU - Conus, Philippe

AU - Cotton, Sue

AU - Robinson, Jo

AU - McGorry, Patrick D

AU - Schimmelmann, Benno G

PY - 2010

Y1 - 2010

N2 - Studies investigating medication adherence in psychosis are limited by the need of a certain degree of medication adherence and the inclusion of mostly multiple-episode patients. By contrast, noninformed consent, epidemiological studies in first-episode psychosis (FEP) allow the assessment of an important subgroup of patients who persistently refuse antipsychotic medication and thereby never receive an adequate antipsychotic trial. The present study aims to assess the prevalence and predictors of such a "medication refusal" subgroup and its association with illness outcome.

AB - Studies investigating medication adherence in psychosis are limited by the need of a certain degree of medication adherence and the inclusion of mostly multiple-episode patients. By contrast, noninformed consent, epidemiological studies in first-episode psychosis (FEP) allow the assessment of an important subgroup of patients who persistently refuse antipsychotic medication and thereby never receive an adequate antipsychotic trial. The present study aims to assess the prevalence and predictors of such a "medication refusal" subgroup and its association with illness outcome.

M3 - SCORING: Zeitschriftenaufsatz

VL - 30

SP - 565

EP - 572

JO - J CLIN PSYCHOPHARM

JF - J CLIN PSYCHOPHARM

SN - 0271-0749

IS - 5

M1 - 5

ER -